Artivion (AORT) Research & Development (2010 - 2026)

Artivion (AORT) has reported Research & Development for 17 consecutive years, with $9.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 28.2% year-over-year to $9.1 million; the trailing twelve-month figure through Jun 2026 stood at $35.1 million (up 26.24% YoY), and the FY2025 full-year result was $31.0 million, up 8.92% from the prior year.
• Research & Development improved to $9.1 million in Q2 2026 per AORT's latest filing, from $8.8 million in the prior quarter.
• Across five years, Research & Development topped out at $11.8 million in Q3 2022 and bottomed at $6.4 million in Q3 2023.
• Historically, Research & Development has averaged $8.1 million across 5 years, with a median of $7.6 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Research & Development tumbled 45.58% in 2023, then surged 31.41% in 2026.
• Over 5 years, Research & Development stood at $8.3 million in 2022, then retreated by 7.94% to $7.6 million in 2023, then decreased by 3.15% to $7.4 million in 2024, then rose by 23.2% to $9.1 million in 2025, then declined by 0.73% to $9.1 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $9.1 million, $8.8 million, and $9.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.